BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 31171967)

  • 1. Trends in antimicrobial resistance in Israel, 2014-2017.
    Dickstein Y; Temkin E; Ish Shalom M; Schwartz D; Carmeli Y; Schwaber MJ
    Antimicrob Resist Infect Control; 2019; 8():96. PubMed ID: 31171967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence and antimicrobial resistance trends in bloodstream infections caused by ESKAPE and Escherichia coli at a large teaching hospital in Rome, a 9-year analysis (2007-2015).
    De Angelis G; Fiori B; Menchinelli G; D'Inzeo T; Liotti FM; Morandotti GA; Sanguinetti M; Posteraro B; Spanu T
    Eur J Clin Microbiol Infect Dis; 2018 Sep; 37(9):1627-1636. PubMed ID: 29948360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antimicrobial resistance in Germany. Four years of antimicrobial resistance surveillance (ARS)].
    Noll I; Schweickert B; Abu Sin M; Feig M; Claus H; Eckmanns T
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2012 Nov; 55(11-12):1370-6. PubMed ID: 23114435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequency of Blood Culture Isolates and their Antibiogram in a Teaching hospital.
    Shrestha S; Amatya R; Shrestha RK; Shrestha R
    JNMA J Nepal Med Assoc; 2014; 52(193):692-6. PubMed ID: 26905550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nosocomial bloodstream infections caused by Escherichia coli and Klebsiella pneumoniae resistant to third-generation cephalosporins, Finland, 1999-2013: Trends, patient characteristics and mortality.
    Martelius T; Jalava J; Kärki T; Möttönen T; Ollgren J; Lyytikäinen O;
    Infect Dis (Lond); 2016; 48(3):229-34. PubMed ID: 26577519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequency of bloodstream infections caused by six key antibiotic-resistant pathogens for prioritization of research and discovery of new therapies in Europe: a systematic review.
    Pezzani MD; Arieti F; Rajendran NB; Barana B; Cappelli E; De Rui ME; Galia L; Hassoun-Kheir N; Argante L; Schmidt J; Rodriguez-Bano J; Harbarth S; de Kraker M; Gladstone BP; Tacconelli E
    Clin Microbiol Infect; 2024 Mar; 30 Suppl 1():S4-S13. PubMed ID: 38007387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenic spectrum of blood stream infections and resistance pattern in Gram-negative bacteria from Aljouf region of Saudi Arabia.
    Bandy A; Almaeen AH
    PLoS One; 2020; 15(6):e0233704. PubMed ID: 32516308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bacterial susceptibility in bloodstream infections: Results from China Antimicrobial Resistance Surveillance Trial (CARST) Program, 2015-2016.
    Zhang F; Li Y; Lv Y; Zheng B; Xue F
    J Glob Antimicrob Resist; 2019 Jun; 17():276-282. PubMed ID: 30611932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Microbiology of Bloodstream Infection: 20-Year Trends from the SENTRY Antimicrobial Surveillance Program.
    Diekema DJ; Hsueh PR; Mendes RE; Pfaller MA; Rolston KV; Sader HS; Jones RN
    Antimicrob Agents Chemother; 2019 Jul; 63(7):. PubMed ID: 31010862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shifting trends and age distribution of ESKAPEEc resistance in bloodstream infection, Southwest China, 2012-2017.
    Yang S; Xu H; Sun J; Sun S
    Antimicrob Resist Infect Control; 2019; 8():61. PubMed ID: 30976388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial resistance trends in bloodstream infections at a large teaching hospital in China: a 20-year surveillance study (1998-2017).
    Tian L; Zhang Z; Sun Z
    Antimicrob Resist Infect Control; 2019; 8():86. PubMed ID: 31161033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in antimicrobial resistance and empiric antibiotic therapy of bloodstream infections at a general hospital in Mid-Norway: a prospective observational study.
    Mehl A; Åsvold BO; Kümmel A; Lydersen S; Paulsen J; Haugan I; Solligård E; Damås JK; Harthug S; Edna TH
    BMC Infect Dis; 2017 Feb; 17(1):116. PubMed ID: 28148226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bloodstream infections and antibiotic resistance patterns: a six-year surveillance study from southern Italy.
    Foglia F; Della Rocca MT; Melardo C; Nastri BM; Manfredini M; Montella F; De Filippis A; Finamore E; Galdiero M
    Pathog Glob Health; 2023 Jun; 117(4):381-391. PubMed ID: 36190133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial resistance of pathogens causing nosocomial bloodstream infection in Hubei Province, China, from 2014 to 2016: a multicenter retrospective study.
    Tian L; Sun Z; Zhang Z
    BMC Public Health; 2018 Sep; 18(1):1121. PubMed ID: 30219056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bacterial and fungal pathogens isolated from patients with bloodstream infection: frequency of occurrence and antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance Program (2012-2017).
    Pfaller MA; Carvalhaes CG; Smith CJ; Diekema DJ; Castanheira M
    Diagn Microbiol Infect Dis; 2020 Jun; 97(2):115016. PubMed ID: 32111415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High Reported Rates of Antimicrobial Resistance in Indian Neonatal and Pediatric Blood Stream Infections.
    Dharmapalan D; Shet A; Yewale V; Sharland M
    J Pediatric Infect Dis Soc; 2017 Sep; 6(3):e62-e68. PubMed ID: 28339675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology and risk factors of methicillin-resistant
    Huang L; Zhang R; Hu Y; Zhou H; Cao J; Lv H; Chen S; Ding S; Chen G
    Antimicrob Resist Infect Control; 2019; 8():90. PubMed ID: 31164979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial Resistance as Risk Factor for Recurrent Bacteremia after Staphylococcus aureus, Escherichia coli, or Klebsiella spp. Community-Onset Bacteremia.
    Abbara S; Guillemot D; Smith DRM; El Oualydy S; Kos M; Poret C; Breant S; Brun-Buisson C; Watier L
    Emerg Infect Dis; 2024 May; 30(5):974-983. PubMed ID: 38666612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial Activities of Ceftaroline and Comparator Agents against Bacterial Organisms Causing Bacteremia in Patients with Skin and Skin Structure Infections in U.S. Medical Centers, 2008 to 2014.
    Sader HS; Flamm RK; Mendes RE; Farrell DJ; Jones RN
    Antimicrob Agents Chemother; 2016 Apr; 60(4):2558-63. PubMed ID: 26856825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Australian Staphylococcus aureus Sepsis Outcome Programme annual report, 2013.
    Coombs GW; Nimmo GR; Daly DA; Le TT; Pearson JC; Tan HL; Robinson JO; Collignon PJ; McLaws ML; Turnidge JD;
    Commun Dis Intell Q Rep; 2014 Dec; 38(4):E309-19. PubMed ID: 25631593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.